New approach to reduce risk of developing type 2 diabetes trialled in Liverpool
An international clinical trial conducted by the University of Liverpool has shown that the drug liraglutide 3.0 mg may reduce diabetes risk by 80% in individuals with obesity and prediabetes according to a study published ...
Feb 22, 2017
0
1